After surging 400% yesterday, Aethlon Medical, Inc. (NASDAQ:AEMD) shares are trading lower after the company announced a 1.38-million share registered direct offering priced at $9 per share.
The gross proceeds to Aethlon, before deducting placement agent fees and other offering expenses, are expected to be approximately $12.425 million.
Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense.
Aethlon Medical’s stock was trading 29.4% lower at $7.62 on Thursday at the time of publication. The stock has a 52-week high of $12.49 and a 52-week low of $1.22.
